16-carboxy-17,18,19,20-tetranor-leukotriene E3

Term ID

CHEBI:74014

Synonyms

(5Z,7E,9E,11R,12S)-11-(L-cystein-S-yl)-12-hydroxyhexadeca-5,7,9-trienedioic acid
(5Z,7E,9E,11R,12S)-11-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-12-hydroxyhexadeca-5,7,9-trienedioic acid
15-carboxy-14,15-dihydro-16,17,18,19,20-pentanor-leukotriene E4
16-carboxy-14,15-dihydro-17,18,19,20-tetranor-leukotriene E4
16-carboxy-14,15-dihydro-17,18,19,20-tetranor-LTE4
16-carboxy-17,18,19,20-tetranor-LTE3
16-carboxy-tetranor-leukotriene E3
16-carboxy-tetranor-LTE3

Definition

An icosanoid that is leukotriene E4 in which the non-conjugated double bond has been reduced to a single bond and four methylene groups have been lost from the resulting carboxyalkyl chain.

References

CAS:122069-63-0
PMID:2174886
PMID:2558763
PMID:7663693
Reaxys:4577467

Ontology

ChEBI ( EBI )

Resources

CTD

Relationships

is a type of: icosanoid L-cysteine thioether non-proteinogenic L-alpha-amino acid secondary alcohol tricarboxylic acid

icosanoid L-cysteine thioether non-proteinogenic L-alpha-amino acid secondary alcohol tricarboxylic acid Show first 5 Terms
has_functional_parent: leukotriene E4

leukotriene E4 Show first 5 Terms
has_role: metabolite

metabolite Show first 5 Terms

Phenotype

Phenotype resulting from 16-carboxy-17,18,19,20-tetranor-leukotriene E3

Phenotype where environments contain 16-carboxy-17,18,19,20-tetranor-leukotriene E3

Phenotype modified by environments containing 16-carboxy-17,18,19,20-tetranor-leukotriene E3

Human Disease Model